Back to search results

Specimen Collection for Medical Research

This study is collecting samples like blood, urine, or skin from volunteers to help researchers at NIAID's Vaccine Research Center learn more about diseases like HIV and hepatitis, how our immune system responds to vaccines or infections, and to develop new vaccines. You can participate if you are 18 years or older and are willing to provide samples that will be used for future research. The study's goal is simply to collect these samples, which will then be used in other research projects. The study status is currently unclear.

Study design
This is an observational study planning to enroll up to 3000 participants. It is not testing a specific drug or intervention.
What's involved
You would provide blood or other samples, which may include ordinary blood draws or apheresis (a procedure to collect more blood cells or plasma).
Compensation
Not stated in the trial record.
Follow-up
Samples will be stored indefinitely for future research, but there are no specific follow-up timeframes for participants within this study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00067054

Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies

Recruiting
Not specifiedAges 3+Observational
National Institute of Allergy and Infectious Diseases (NIAID)
~3,000 participants
Updated 2026-09-16 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Sample collection only
Measured over end of study

Conditions

Sample Collection

Explore related trials

Healthy VolunteersInfectious Disorder

NCT00067054

Where you'd take part

This study runs at 3 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • National Institutes of Health Clinical Center

    Bethesda, Marylandstudy coordinator listed

    Recruiting

  • EvergreenHealth Medical Center

    Kirkland, Washingtonno site contact published

    Completed

  • University of Puerto Rico Medical Sciences Campus

    San Juan, Puerto Ricono site contact published

    Active, not recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Lesia K Dropulic, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Allergy and Infectious Diseases (NIAID)

Who to contact

OPS Team, VRC
[email protected]
Not Listed
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

To undergo an apheresis procedure, a participant must have no medical contraindications. All apheresis procedures performed under this protocol are solely for research purposes.
Participants involved in an active clinical research protocol may participate in the apheresis protocol if the total amount of blood drawn does not exceed NIH guidelines or a site's institutional guidelines. A study clinician will complete a checklist for apheresis eligibility before referring a participant for apheresis.
At the NIH, prior to the scheduled procedure, the participant must have a venous assessment performed by apheresis staff to determine suitability for apheresis.

What this trial measures

  • Sample collection onlyend of study

    This protocol does not have an analysis primary outcome measure, but rather will be conducted in accordance with Good Clinical Practices for human research solely for the purpose of obtaining samples for research laboratories. Samples will be identified only by protocol identification number. Participant data, such as demographic information, aspects of medical history, laboratory parameters, recent immunizations or medications, HLA type, genetic tests and other medical information may be provided (identified by study number, but not subject name) to researchers if needed to support the objectives of the laboratory research.